Stevanato Group partners with Aptar Pharma on pre-filled syringe system testing
STVN•Stevanato Group and Aptar Pharma will jointly test prefilled syringe systems for biologics and other injectable therapies, combining glass syringes with elastomer components to assess performance and identify technical risks earlier in development.
1. Joint testing collaboration
Stevanato Group entered a collaboration with Aptar Pharma to support earlier selection of prefilled syringe systems for biologics and other injectable therapies. Their joint testing will combine glass syringes with elastomer components to assess system performance and help drugmakers identify technical risks earlier in development.
2. Building on framework
The work builds on Aptar Pharma’s integrated system-level framework launched in July 2026.
